Sabra Health Care REIT Inc.

SBRA
Financial Analysis · Updated May 13, 2026 · Coverage 2026-Q2
Latest Q Revenue
$221.8M
Q1 FY2026 · +17.4% YoY
TTM ROIC
7%
FY2025 · AFFO / Total Invested Capital (AFFO ROTC) · WACC ~6.75% · Moat spread +0.25pp
Margin Profile
Gross 68%
Operating 35%
FY2024
Net Debt
$3.0B
Cash $50M · Debt $3.0B · FY2024
Diluted Shares
254M
FY2025

Business Overview


ticker: SBRA step: 01 generated: 2026-05-13 source: quick-research

Sabra Health Care REIT Inc. (SBRA) — Business Overview

Business Description

Sabra Health Care REIT is a self-administered, self-managed REIT that owns and invests in healthcare real estate across the United States and Canada. The company's portfolio of 364 properties includes skilled nursing/transitional care facilities, senior housing communities (both triple-net leased and managed), behavioral health facilities, and specialty hospitals. A key strategic shift is underway: Sabra is intentionally increasing its exposure to Senior Housing Operating Properties (SHOP) — managed senior housing where Sabra participates in operating upside — from approximately 20% to 30% of the portfolio by year-end 2026.

Revenue Model

Revenue comes from two primary sources: (1) triple-net lease rental income from skilled nursing and leased senior housing operators (predictable, fixed rent + escalators; tenant bears operating costs); and (2) SHOP revenue — Sabra receives the gross operating revenue of managed senior housing communities (minus property management fees), bearing both the upside and downside of occupancy and rate changes. The SHOP model is riskier but allows Sabra to capture the full value of occupancy and rate improvement in the senior housing recovery cycle.

Products & Services

  • Skilled nursing/transitional care facility ownership (224 facilities — largest segment)
  • Senior housing leased (39 communities, triple-net)
  • Senior Housing Operating Properties — SHOP (69 managed communities)
  • Behavioral health facility ownership (17 facilities)
  • Specialty hospital and other healthcare real estate (15 facilities)
  • Mortgage and other investments in healthcare operators

Customer Base & Go-to-Market

Skilled nursing operators (regional chains and private operators), senior living operators, behavioral health operators, and specialty hospital systems. Sabra's SHOP tenants are run by third-party professional property managers under management contracts. The company sources acquisitions through broker networks, direct relationships with healthcare operators, and sale-leaseback negotiations.

Competitive Position

Mid-sized healthcare REIT in a sector dominated by Welltower and Ventas. Sabra's differentiation is its focus on skilled nursing (a segment many REITs have reduced after COVID-era reimbursement pressures) and its growing SHOP platform as a vehicle for occupancy-led earnings recovery. Trading at approximately 12.7x 2026 FAD — below the ~20.6x average for SHOP-exposed healthcare REIT peers — suggests meaningful multiple expansion potential if the SHOP strategy executes.

Key Facts

  • Founded: 2010
  • Headquarters: Irvine, California
  • Employees: ~30 (lean; REIT structure with third-party operators)
  • Exchange: NASDAQ
  • Sector / Industry: Real Estate / Healthcare REITs (Skilled Nursing & Senior Housing)
  • Market Cap: ~$4–5B

Financial Snapshot


ticker: SBRA step: 04 generated: 2026-05-13 source: quick-research

Sabra Health Care REIT Inc. (SBRA) — Financial Snapshot

Income Statement Summary

Metric FY2022 FY2023 FY2024 YoY
Revenue $647M $703M $733M +4.2%
Gross Margin ~65% ~67% ~68%
Operating Margin ~30% ~32% ~35%
Net Income ~$50M ~$80M ~$100M
Normalized AFFO/Share ~$1.25 ~$1.35 $1.44 +7.0%

GAAP net income is depressed by depreciation. Normalized AFFO is the primary metric — growing 7% in FY2024. Normalized FFO/share grew 7% to $1.39 in FY2024. Last-12-month FFO (as of early 2026): $370.7M, up from $321.6M a year earlier (+15.3%).

Cash Flow & Balance Sheet (FY2024)

Metric Value
Operating Cash Flow ~$350M
Normalized AFFO ~$370M
Cash & Equivalents ~$50M
Total Debt ~$3.0B
Net Debt / EBITDA ~6.5x

Key Ratios (approximate)

  • P/Normalized AFFO: ~12x | EV/EBITDA: ~16x | Dividend Yield: ~6.4%
  • Revenue Growth (FY2024): +4.2% | Normalized AFFO/Share Growth: +7.0%
  • SHOP Sequential Revenue Growth (Q4 2024): +15.8%; Cash NOI Growth: +18.4%
  • Payout Ratio: ~80% (80% payout on $1.495 FY2025 AFFO guidance)

Growth Profile

Sabra has delivered consistent 4–8% revenue growth since 2022, driven by improving SNF occupancy post-COVID, senior housing rent escalations, and acquisitions. The SHOP segment is the primary growth accelerator: managed senior housing NOI grew 18.4% sequentially in Q4 2024 as occupancy approached 88% (target: low-90s). The strategic shift toward 30% SHOP exposure by end-2026 is designed to capture the senior housing occupancy recovery cycle — Sabra's earnings growth should accelerate as SHOP occupancy improves and the portfolio mix shifts toward higher-margin managed assets.

Forward Estimates

  • FY2025 Normalized AFFO/share guidance: $1.495
  • FY2026 Normalized FFO/AFFO guidance growth: +4.9–5.4% at midpoint
  • SHOP occupancy target: low-90% range (from ~88%)
  • Investment target: >$500M in acquisitions (exceeding initial $500M guidance in 2025)
  • Analysts: Bullish consensus; 12.7x 2026 FAD (vs. peer average ~20.6x — significant discount)

Deeper Financial Analysis

The fundamental tier adds 9 additional research dimensions for $SBRA.

Revenue Breakdown
Segment revenue, geographic mix, product-line contribution margins, and cohort dynamics.
Financial Trends
Quarter-over-quarter momentum, leading indicators, and inflection point analysis.
Balance Sheet
Debt structure, liquidity runway, dilution risk, and working capital dynamics.
Capital Allocation
Buyback cadence, M&A appetite, dividend policy, and reinvestment priorities.
Returns on Capital (ROIC)
Multi-year ROIC vs. WACC, marginal returns on reinvestment, sales-to-invested-capital efficiency, and moat spread.
GET /api/v1/research/SBRA/fundamental$1.00 · Bearer token required
Markdown: /stocks/sbra/financials/md · → thesis · → memo